![]() It floated last autumn after a bumper period of fundraisings and other deals and did warn that it would not achieve the same levels of revenues and profit, but it turned out worse than expected due to delayed deals. None more so than broker Peel Hunt (LSE:PEEL). Some companies joined AIM when their markets were peaking. The previously mentioned ATOME Energy, which was spun out of President Energy (LSE:PPC), has risen by 17.5% although the share price has been highly volatile. Acquisitions have helped to enhance the business, although the share price is well below its high. The flip side was the potential to secure sites at attractive rents. It floated at the beginning of 2021 when investors were required to be brave to be putting their money into bars and restaurants when lockdowns where still in force. In contrast, bars operator Nightcap (LSE:NGHT) is 45% higher. Laboratories and pharma offices investor Life Science REIT (LSE:LABS), a more solid investment, has drifted lower by 5.9%. Technology investor Forward Partners (LSE:FWD) has fallen 54.5% and biotech Poolbeg Pharma (LSE:POLB), which was spun out of Open Orphan (LSE:ORPH), is 53% lower. This is an example of a high-profile business attracting investors at a premium valuation and failing to live up to optimistic expectations. The worst-performing new admission from last year is delivered meals provider Parsley Box (LSE:MEAL), which offered shares via PrimaryBid and the share price has dived by 95.1%. ![]() This shows that investors need to be choosy. Six of these AIM companies that joined AIM in 2021 offered small investors the chance to be involved in their flotations, but the outcomes have not been that good to say the least. Investors are keen to gain access to new companies joining the London markets. There are 11 companies where share prices have risen during 2022 and three of those are still below their flotation prices. Read more AIM articles by Andrew Hore hereĪIM has fallen by 24% so far in 2022, and there are 45 of last year’s AIM admissions that have fallen by more than the junior market this year.Five AIM share tips for 2022: a brutal first half.Hydrogen production projects developer Atome Energy (LSE:ATOM) and electric motor technology developer Saietta Group (LSE:SED) are higher, but battery technology developer Amte Power (LSE:AMTE), even though it has made some positive announcements about its new facility and partners, and energy storage developer Gelion (LSE:GELN)have slumped in value. There was a spate of clean-tech and renewables companies floating last year, and their performance has been mixed. Both dipped below their placing prices during last year. However, there is quite a mix of companies with gains, such as food wholesaler Kitwave (LSE:KITW) and software training provider Northcoders (LSE:CODE), which have both published positive trading updates. Some of the better performers are resources companies, including oil and gas and mining. Coal miner Bens Creek (LSE:BEN) has more than halved from its peak, but it is still 275% ahead. That seems part of the reason why it has risen by 436%. The best performer is 4basebio (LSE:4BB), which was spun out of another company and liquidity is limited. There are some companies that have done particularly well. There were 19 companies where share prices have at least halved since flotation, compared with 20 where share prices have risen. Read about how to: Open a Trading Account | How to start Trading Stocks | Top UK shares. ![]() Many of these companies went to a premium in initial dealings. That means that there are 72 companies included in the analysis and 52 of these are below their issue prices. The figures include the new companies that joined AIM and not the reverse takeovers and readmissions, or the five companies that moved from the Main Market to AIM. However, even though there were more companies joining AIM and more was raised by them then since 2014, it was not generally good for the investors in most of these companies. ![]() Last year was one of the busiest for AIM new admissions for nearly a decade. Our award-winning AIM writer reflects on a bumper year for new admissions to the junior market, and names the winners and losers in performance terms. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |